A brief review on resistance to P2Y(12) receptor antagonism in coronary artery disease

BACKGROUND: Platelet inhibition is important for patients with coronary artery disease. When dual antiplatelet therapy (DAPT) is required, a P2Y(12)-antagonist is usually recommended in addition to standard aspirin therapy. The most used P2Y(12)-antagonists are clopidogrel, prasugrel and ticagrelor....

Descripción completa

Detalles Bibliográficos
Autores principales: Warlo, Ellen M. K., Arnesen, Harald, Seljeflot, Ingebjørg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558673/
https://www.ncbi.nlm.nih.gov/pubmed/31198410
http://dx.doi.org/10.1186/s12959-019-0197-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558673/
https://www.ncbi.nlm.nih.gov/pubmed/31198410
http://dx.doi.org/10.1186/s12959-019-0197-5

Ejemplares similares